“prediction markets are replacing expert opinion across pharma, climate, and supply chains”
Makes the case for prediction markets as a corporate treasury and forecasting tool, backed by data on 127x volume growth from 2022 to 2025. Profiles Enlivex's use of the Rain protocol on Arbitrum as its primary reserve asset, and traces how prediction markets are displacing expert opinion in pharma, climate science, and supply chain management.
Some technical background helpful
Platforms mentioned: Rain